The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
about
Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressureSLE with recurrent heart failure and a dermatological clue to another added possibilityPulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsyNOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.Persistent vascular collagen accumulation alters hemodynamic recovery from chronic hypoxiaConsensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.Heart involvement and systemic sclerosis.Acute manifestations of autoimmune connective tissue diseases.Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?Scleroderma-related lung disease: are adipokines involved pathogenically?Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease.Care of patients with scleroderma in the intensive care setting.Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice.
P2860
Q33923465-9F3F196B-6711-49E4-81F8-24D94FC355AEQ34143652-F99BDB1C-1314-4D68-9F9F-026C747BD456Q34816370-6E4344BE-B84D-4614-BE79-182897DE06A8Q35591616-E4E095BD-85F8-4C33-B8A2-DDC142B732A2Q35597574-334E7311-2BF1-41E7-92C0-44A0E7F036FEQ35605567-D1C3F34E-4715-4678-A630-57FE42497A4BQ35803193-E2B69085-CE12-4F8D-B122-19292A94A1A1Q35934224-29C824EB-0055-411F-92B9-B5514A478903Q36283456-FC7F182F-FEDE-49DE-922C-7AC091C35988Q36490337-B8229BA0-1A54-4420-B356-F750C9E84B6DQ36836706-4D814C3D-200C-421E-9886-DD8CE1A247B5Q37408223-6CFE9E35-4574-4A39-9736-66AEBED2A81EQ37555367-93A1E4F8-9831-46B8-9FE2-A0EAF2F9D942Q37764618-5F724E84-105F-46D3-A9F0-A95F2366B6B5Q42440126-E33C7D85-6AF1-4422-A80C-4263532F18A3
P2860
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@ast
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@en
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@nl
type
label
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@ast
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@en
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@nl
prefLabel
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@ast
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@en
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@nl
P1476
The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.
@en
P2093
Coghlan JG
Mukerjee D
P304
P356
10.1097/00002281-200111000-00008
P577
2001-11-01T00:00:00Z